Immunovant, Inc. (IMVT) vs Ligand Pharmaceuticals Incorporated (LGND)

• Immunovant, Inc. IMVT 30.53 ▲ +7.54%
• Ligand Pharmaceuticals Incorporated LGND 306.43 ▲ +2.48%

Immunovant, Inc. and Ligand Pharmaceuticals Incorporated are both Biotechnology companies. Immunovant, Inc. and Ligand Pharmaceuticals Incorporated are of similar size ($6.0B and $5.9B). Immunovant, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 116×. Ligand Pharmaceuticals Incorporated has the higher net margin (20.3% vs 0.00%) and the higher return on invested capital (1.27% vs 0.00%). Across the 14 metrics below, Ligand Pharmaceuticals Incorporated leads on 12 and Immunovant, Inc. on 2.